(Q44065050)

29 November 2017

An association between NQO1 genetic polymorphism and risk of bladder cancer (English)

1 reference

29 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694753

24 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1383-5718(03)00041-X

24 December 2023

author name string

Seun-Ja Park

1

1 reference

29 November 2017

Hua Zhao

2

1 reference

29 November 2017

Xifeng Wu

5

1 reference

29 November 2017

Margaret R. Spitz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694753

24 December 2023

H. Barton Grossman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694753

24 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

29 November 2017

20 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12694753

full work available at URL

24 December 2023

https://api.elsevier.com/content/article/PII:S138357180300041X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1383-5718(03)00041-X

https://api.elsevier.com/content/article/PII:S138357180300041X?httpAccept=text/plain

24 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1383-5718(03)00041-X

24 December 2023

1 reference

29 November 2017

536

1 reference

29 November 2017

131-137

1 reference

29 November 2017

1-2

1 reference

NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Conversion of 4-nitroquinoline 1-oxide (4NQO) to 4-hydroxyaminoquinoline 1-oxide by a dicumarol-resistant hepatic 4NQO nitroreductase in rats and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Purified NAD(P)H-quinone oxidoreductase enhances the mutagenicity of dinitropyrenes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

NAD(P)H: quinone oxidoreductase polymorphism and lung cancer in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

Differences in lung cancer risk between men and women: examination of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2803%2900041-X

7 January 2021

The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior

12

1 reference

https://api.crossref.org/works/10.1016/S1383-5718(03)00041-X

Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes

24 December 2023

15

1 reference

https://api.crossref.org/works/10.1016/S1383-5718(03)00041-X

24 December 2023

Identifiers

1 reference

29 November 2017

1 reference